Unbiased AI-powered news
Researchers use lab-grown organoids to model human brain development and study diseases. These three-dimensional structures mimic brain tissue and enable detailed analysis of cellular processes. The approach provides insights into conditions such as microcephaly and Zika virus effects.
Substrate placeholder — needs reviewLab-grown organoids, which are three-dimensional structures derived from human stem cells, are used to study brain development and related diseases. These organoids replicate aspects of brain tissue organization and function. Scientists reported on their application in a recent article in Nature.
Organoids allow researchers to observe brain development in a controlled environment. They form neural structures similar to those in human embryos. This method facilitates the examination of genetic and environmental factors influencing brain growth.
Studies have applied organoids to investigate neurodevelopmental disorders. For example, researchers modeled microcephaly, a condition involving reduced brain size, using patient-derived cells. The organoids revealed disruptions in neural progenitor cell proliferation.
have been used to study the impact of Zika virus on brain development.
Infected organoids showed reduced growth and increased cell death, mirroring effects observed in affected fetuses. This approach helps identify potential therapeutic targets. The technology also aids in understanding autism spectrum disorders and schizophrenia.
By comparing organoids from healthy and diseased individuals, researchers identify differences in gene expression and cell connectivity. These findings contribute to broader knowledge of brain function.
work focuses on improving organoid complexity to better simulate the full brain.
Challenges include vascularization and integration of multiple cell types. Advances in this area could enhance drug testing and personalized medicine approaches. Researchers emphasize the ethical considerations of using human-derived tissues.
Guidelines ensure responsible use in studies. The method remains a key tool for non-invasive brain research.
Single source — no framing comparison available.
New ScientistThe LiBBY trial of purified THC and CBD in a rapid-acting oil showed nearly 90 percent of 120 participants improved after 12 weeks. Results were presented at the Alzheimer’s Association International Conference but have not been peer reviewed.
comicbook.comDisney's live-action remake earned $43 million in the United States and Canada and $52 million internationally over its first three days. The $250 million film finished first at the domestic box office despite falling short of studio estimates.
rt.comEstimates attribute around 550 deaths to late May and nearly 2,200 to mid-to-late June. June 2026 set a new record for warmth in England.